Processa Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCSA and other ETFs, options, and stocks.About PCSA
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.
PCSA Key Statistics
Stock Snapshot
The current Processa Pharmaceuticals(PCSA) stock price is $3.74, with a market capitalization of 8.59M. The stock trades at a price-to-earnings (P/E) ratio of -0.11.
As of 2025-12-22, Processa Pharmaceuticals(PCSA) stock has fluctuated between $3.71 and $3.80. The current price stands at $3.74, placing the stock +0.8% above today's low and -1.6% off the high.
Processa Pharmaceuticals(PCSA) shares are trading with a volume of 20.41K, against a daily average of 4.41M.
During the past year, Processa Pharmaceuticals(PCSA) stock moved between $2.74 at its lowest and $27.00 at its peak.
During the past year, Processa Pharmaceuticals(PCSA) stock moved between $2.74 at its lowest and $27.00 at its peak.
PCSA News
The average one-year price target for Processa Pharmaceuticals (NasdaqCM:PCSA) has been revised to $25.50 / share. This is an increase of 2,400.00% from the pri...
Penny stock Processa Pharmaceuticals (PCSA) surged as much as 130% on Wednesday. The upside is due to encouraging preliminary data from its ongoing Phase 2 stud...
Processa Pharmaceuticals (PCSA) provided a clinical update on its ongoing Phase 2 study of NGC-Cap, the combination treatment of PCS6422 and capecitabine, in pa...